Bupivacaine Hydrochloride In · 3,125 days since initial FDA posting
Brand: BUPIVACAINE HYDROCHLORIDE
FDA lists Bupivacaine Hydrochloride In as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Bupivacaine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bupivacaine Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)
- Package NDC
- 0409-1159-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 20, 2018
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Bupivacaine Shortage Records
Bupivacaine Hydrochloride Injection
Somerset Therapeutics, LLC
Injection
Bupivacaine Hydrochloride Injection
Somerset Therapeutics, LLC
Injection
Bupivacaine Hydrochloride Injection
Kindos Pharmaceuticals Co. Ltd.
Injection
Bupivacaine Hydrochloride Injection
Kindos Pharmaceuticals Co. Ltd.
Injection
Bupivacaine Hydrochloride Injection
Kindos Pharmaceuticals Co. Ltd.
Injection
Bupivacaine Hydrochloride Injection
Kindos Pharmaceuticals Co. Ltd.
Injection